SAN DIEGO, June 16, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced that it has entered into a contractual agreement as a participating provider with Prime Health Services to provide ...
Astellas Pharma US will stop distributing Xtandi, a prostate cancer drug that costs about $160,000 each year, to 340B contract pharmacies on Sept. 1, according to a letter obtained by 340B Health. In ...
A saliva swab could help quickly identify the men most at risk of prostate cancer after UK researchers tracked down a host of genetic changes that make the disease up to four times more likely. The ...
Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Although all men have one, the prostate continues to be a puzzling gland, prone to cancer, beset ...
The IAEA is launching a year-long coordinated research project to develop computed tomography-based guidelines on prostate cancer contouring — a critical step in the cancer treatment process that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback